<?xml version="1.0" encoding="UTF-8"?>
<p>The authors support the inclusion of anti-HBs in the serological screening markers (HBsAg, anti-HBc) as suggested by recent American Association for the Study of Liver Diseases (AASLD) and European Association for the Study of the Liver (EASL) guidelines,
 <sup>
  <xref rid="bibr10-1759720X20912646" ref-type="bibr">10</xref>,
  <xref rid="bibr11-1759720X20912646" ref-type="bibr">11</xref>
 </sup> in order to identify cases that may benefit from initial or booster vaccination, but also cases of occult HBV infection in anti-HBs positive patients that have not been vaccinated in the past and have lost their anti-HBc.
</p>
